Filing Flows › Pulmatrix (PULM) › Q4 2024 › vs Q4 2023
Pulmatrix (PULM) Q4 2024 vs Q4 2023 (year over year)
Pulmatrix's revenue fell $2.2M (-100%) from $2.2M in Q4 2023 to $3K in Q4 2024.
Pulmatrix, Q4 2024: revenue $3K (-100% year over year), net loss $2.0M, operating cash flow −$1.3M. The chart draws each line against Q4 2023, the increases inside each band.
Every line
| Line | Q4 2024 | Q4 2023 | Change | % |
|---|---|---|---|---|
| Revenue | $3K | $2.2M | −$2.2M | -100% |
| Net loss | $2.0M | $2.1M | −$97K | -5% |
| Costs & expenses | $2.0M | $4.4M | −$2.4M | -55% |
| Operating costs | $2.0M | $4.4M | −$2.5M | -56% |
| Interest & other, net | $34K | −$142K | $176K | — |
| Research & development | $6K | $3.5M | −$3.5M | -100% |
| General & admin | $1.9M | $911K | $1.0M | +114% |
| Operating cash sources | $2.0M | $2.0M | −$59K | -3% |
| Share-based compensation | $13K | $197K | −$184K | -93% |
| Working capital & other | $712K | −$163K | $875K | — |
| Cash used in operations | $1.3M | $2.0M | −$750K | -37% |
| Net loss absorbed | $2.0M | $2.1M | −$97K | -5% |
Questions
How much did Pulmatrix's revenue grow year over year in Q4 2024?
Pulmatrix's revenue fell $2.2M (-100%) from $2.2M in Q4 2023 to $3K in Q4 2024.